Inventor · disambiguated record
Brian W. Metcalf
Also filed as: JUNG MICHEL · METCALF BRIAN · METCALF BRIAN W · METCALF BRIAN WALTER
134 granted patents·40 pending applications·2,320 citations·filing 1975–2025
99Inventor score
Files withINCYTE CORP44GLOBAL BLOOD THERAPEUTICS INC38MERRELL TORAUDE & CO15SMITHKLINE BEECHAM CORP14YAO WENQING13
Top patents by PatentIndex Score
174 records- 0199US10034879B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·36 cites·2 claims
- 0299US10017491B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·34 cites·1 claims
- 0399US7767675B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Aug 3, 2010·85 cites·85 claims
- 0498US10377741B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·15 cites·5 claims
- 0598US9422279B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Aug 23, 2016·50 cites·25 claims
- 0698US9290506B2Processes for preparing JAK inhibitors and related intermediate compoundsINCYTE CORP·Filed 2015·Granted Mar 22, 2016·60 cites·1 claims
- 0798US9248199B21:1 adducts of sickle hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Feb 2, 2016·43 cites·2 claims
- 0898US9018210B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 28, 2015·56 cites·6 claims
- 0998US9000161B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Apr 7, 2015·67 cites·25 claims
- 1098US8993582B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Mar 31, 2015·60 cites·1 claims
- 1198US8940752B2Pyrimidinones as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Jan 27, 2015·62 cites·16 claims
- 1298US8410265B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2010·Granted Apr 2, 2013·136 cites·4 claims
- 1397US11401280B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Aug 2, 2022·4 cites·32 claims
- 1497US10125150B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2018·Granted Nov 13, 2018·15 cites·31 claims
- 1597US9988401B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jun 5, 2018·14 cites·27 claims
- 1697US9957250B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·19 cites·6 claims
- 1797US9458139B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Oct 4, 2016·45 cites·24 claims
- 1897US9434746B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2014·Granted Sep 6, 2016·32 cites·25 claims
- 1997US8461330B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2010·Granted Jun 11, 2013·40 cites·25 claims
- 2097US6489314B1Epothilone derivatives and methods for making and using the sameKOSAN BIOSCIENCES INC·Filed 2001·Granted Dec 3, 2002·60 cites·27 claims
- 2196US7776874B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2008·Granted Aug 17, 2010·27 cites·24 claims
- 2296US7304081B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Dec 4, 2007·42 cites·25 claims
- 2396US3960927AOlefinic derivatives of amino acidsRICHARDSON MERRELL INC·Filed 1975·Granted Jun 1, 1976·78 cites·6 claims
- 2495US10428087B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Oct 1, 2019·13 cites·39 claims
- 2595US9975907B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted May 22, 2018·14 cites·51 claims
- 2695US9944645B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE HOLDINGS CORP·Filed 2016·Granted Apr 17, 2018·15 cites·15 claims
- 2795US9908888B2Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidinesINCYTE HOLDINGS CORP·Filed 2016·Granted Mar 6, 2018·6 cites·8 claims
- 2895US8058288B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2010·Granted Nov 15, 2011·22 cites·35 claims
- 2994US10435393B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·14 cites·11 claims
- 3094US10100043B2Substituted aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·15 cites·26 claims
- 3194US9126927B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2011·Granted Sep 8, 2015·20 cites·33 claims
- 3294US9012450B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 21, 2015·46 cites·14 claims
- 3394US6589968B2Epothilone compounds and methods for making and using the sameKOSAN BIOSCIENCES INC·Filed 2001·Granted Jul 8, 2003·49 cites·8 claims
- 3494US4317817ANovel steroid 5α-reductase inhibitorsRICHARDSON MERRELL INC·Filed 1980·Granted Mar 2, 1982·56 cites·16 claims
- 3594US4180509Aα-Ethynyl tryptophanesMERRELL TORAUDE & CO·Filed 1977·Granted Dec 25, 1979·30 cites·8 claims
- 3693US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 3793US8071624B2N-substituted piperidines and their use as pharmaceuticalsYAO WENQING·Filed 2005·Granted Dec 6, 2011·26 cites·43 claims
- 3892US10829502B2Pyrimidinones as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Nov 10, 2020·7 cites·30 claims
- 3992US10738052B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·3 cites·18 claims
- 4092US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 4192US9801877B2AZA spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2016·Granted Oct 31, 2017·7 cites·18 claims
- 4292US7687665B22-methylprop anamides and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Mar 30, 2010·24 cites·28 claims
- 4391US7307086B23-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptorsINCYTE CORP·Filed 2005·Granted Dec 11, 2007·21 cites·24 claims
- 4491US4910226ASteroid 5-alpha-reductase inhibitorsSMITHKLINE BECKMAN CORP·Filed 1987·Granted Mar 20, 1990·64 cites·14 claims
- 4590US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 4690US7511050B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2007·Granted Mar 31, 2009·14 cites·110 claims
- 4790US5110939AIntermediates in the preparation of steriod 5-alpha-reductase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1989·Granted May 5, 1992·28 cites·3 claims
- 4890US4882319APhosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductaseSMITHKLINE BECKMAN CORP·Filed 1988·Granted Nov 21, 1989·57 cites·24 claims
- 4989US9957229B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2017·Granted May 1, 2018·4 cites·6 claims
- 5089US7723349B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2004·Granted May 25, 2010·21 cites·15 claims
Showing the top 50 of 174 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →